CAH vs CAPR · P/E 35, rev $254.25B vs $1.62B cap
Cardinal Health Inc (CAH) versus Capricor Therapeutics Inc (CAPR) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. CAPR currently screens at market cap $1.62B.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. CAPR currently screens at market cap $1.62B.
Not investment advice. Open the CAH and CAPR stock pages for the full models.
Not investment advice.